David J. Bearss,Steven L. Warner,Clifford J. Whatcott
申请号：
US16382726
公开号：
US20190314357A1
申请日:
2019.04.12
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Methods for treating cancer by administration of two or more therapeutic agents are provided. The two or more therapeutic agents include a cyclin-dependent kinase inhibitor (e.g., alvocidib) and an anthracycline (e.g., daunorubicin or idarubicin). Kits comprising the two or more therapeutic agents that can be used to perform such methods are also provided.
